CPHI
Price
$1.65
Change
+$0.10 (+6.45%)
Updated
Apr 24, 02:15 PM (EDT)
Capitalization
18.31M
SIGA
Price
$6.39
Change
+$0.15 (+2.40%)
Updated
Apr 24, 03:34 PM (EDT)
Capitalization
608.54M
7 days until earnings call
Ad is loading...

CPHI vs SIGA

Header iconCPHI vs SIGA Comparison
Open Charts CPHI vs SIGABanner chart's image
China Pharma Holdings
Price$1.65
Change+$0.10 (+6.45%)
Volume$100
Capitalization18.31M
SIGA Technologies
Price$6.39
Change+$0.15 (+2.40%)
Volume$705
Capitalization608.54M
CPHI vs SIGA Comparison Chart
Loading...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPHI vs. SIGA commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPHI is a Hold and SIGA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (CPHI: $1.55 vs. SIGA: $6.24)
Brand notoriety: CPHI and SIGA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CPHI: 36% vs. SIGA: 115%
Market capitalization -- CPHI: $18.31M vs. SIGA: $608.54M
CPHI [@Pharmaceuticals: Other] is valued at $18.31M. SIGA’s [@Pharmaceuticals: Other] market capitalization is $608.54M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPHI’s FA Score shows that 0 FA rating(s) are green whileSIGA’s FA Score has 2 green FA rating(s).

  • CPHI’s FA Score: 0 green, 5 red.
  • SIGA’s FA Score: 2 green, 3 red.
According to our system of comparison, SIGA is a better buy in the long-term than CPHI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPHI’s TA Score shows that 5 TA indicator(s) are bullish while SIGA’s TA Score has 6 bullish TA indicator(s).

  • CPHI’s TA Score: 5 bullish, 6 bearish.
  • SIGA’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, SIGA is a better buy in the short-term than CPHI.

Price Growth

CPHI (@Pharmaceuticals: Other) experienced а -0.64% price change this week, while SIGA (@Pharmaceuticals: Other) price change was +5.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.44%. For the same industry, the average monthly price growth was -4.70%, and the average quarterly price growth was -11.48%.

Reported Earning Dates

CPHI is expected to report earnings on Mar 31, 2025.

SIGA is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.44% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SIGA($609M) has a higher market cap than CPHI($18.3M). SIGA YTD gains are higher at: 3.827 vs. CPHI (-33.333). SIGA has less debt than CPHI: SIGA (564K) vs CPHI (5.39M).
CPHISIGACPHI / SIGA
Capitalization18.3M609M3%
EBITDAN/A84.2M-
Gain YTD-33.3333.827-871%
P/E RatioN/A9.24-
RevenueN/A140M-
Total CashN/A150M-
Total Debt5.39M564K956%
FUNDAMENTALS RATINGS
CPHI vs SIGA: Fundamental Ratings
CPHI
SIGA
OUTLOOK RATING
1..100
327
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
1
Undervalued
PROFIT vs RISK RATING
1..100
10083
SMR RATING
1..100
9533
PRICE GROWTH RATING
1..100
9054
P/E GROWTH RATING
1..100
10066
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIGA's Valuation (1) in the Pharmaceuticals Other industry is somewhat better than the same rating for CPHI (46) in the Pharmaceuticals Generic industry. This means that SIGA’s stock grew somewhat faster than CPHI’s over the last 12 months.

SIGA's Profit vs Risk Rating (83) in the Pharmaceuticals Other industry is in the same range as CPHI (100) in the Pharmaceuticals Generic industry. This means that SIGA’s stock grew similarly to CPHI’s over the last 12 months.

SIGA's SMR Rating (33) in the Pharmaceuticals Other industry is somewhat better than the same rating for CPHI (95) in the Pharmaceuticals Generic industry. This means that SIGA’s stock grew somewhat faster than CPHI’s over the last 12 months.

SIGA's Price Growth Rating (54) in the Pharmaceuticals Other industry is somewhat better than the same rating for CPHI (90) in the Pharmaceuticals Generic industry. This means that SIGA’s stock grew somewhat faster than CPHI’s over the last 12 months.

SIGA's P/E Growth Rating (66) in the Pharmaceuticals Other industry is somewhat better than the same rating for CPHI (100) in the Pharmaceuticals Generic industry. This means that SIGA’s stock grew somewhat faster than CPHI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPHISIGA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 9 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMARX53.39N/A
N/A
ClearBridge Small Cap R
WEBAX9.61N/A
N/A
TETON Westwood Balanced AAA
FPADX10.61N/A
N/A
Fidelity Emerging Markets Idx
PMJAX9.27N/A
N/A
PIMCO RAE US Small A
DESRX20.02N/A
N/A
DWS ESG Core Equity R

CPHI and

Correlation & Price change

A.I.dvisor tells us that CPHI and TAK have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPHI and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPHI
1D Price
Change %
CPHI100%
-4.91%
TAK - CPHI
28%
Poorly correlated
-0.98%
HCM - CPHI
24%
Poorly correlated
-2.69%
YCBD - CPHI
23%
Poorly correlated
+0.59%
SIGA - CPHI
23%
Poorly correlated
+1.79%
PAHC - CPHI
22%
Poorly correlated
+0.76%
More